| Literature DB >> 35161881 |
Alberto Tena1, Francesc Clarià2, Francesc Solsona2, Mònica Povedano3.
Abstract
The term "bulbar involvement" is employed in ALS to refer to deterioration of motor neurons within the corticobulbar area of the brainstem, which results in speech and swallowing dysfunctions. One of the primary symptoms is a deterioration of the voice. Early detection is crucial for improving the quality of life and lifespan of ALS patients suffering from bulbar involvement. The main objective, and the principal contribution, of this research, was to design a new methodology, based on the phonatory-subsystem and time-frequency characteristics for detecting bulbar involvement automatically. This study focused on providing a set of 50 phonatory-subsystem and time-frequency features to detect this deficiency in males and females through the utterance of the five Spanish vowels. Multivariant Analysis of Variance was then used to select the statistically significant features, and the most common supervised classifications models were analyzed. A set of statistically significant features was obtained for males and females to capture this dysfunction. To date, the accuracy obtained (98.01% for females and 96.10% for males employing a random forest) outperformed the models in the literature. Adding time-frequency features to more classical phonatory-subsystem features increases the prediction capabilities of the machine-learning models for detecting bulbar involvement. Studying men and women separately gives greater success. The proposed method can be deployed in any kind of recording device (i.e., smartphone).Entities:
Keywords: ALS; bulbar involvement; diagnosis; machine learning; phonatory subsystem; time frequency; voice
Mesh:
Year: 2022 PMID: 35161881 PMCID: PMC8837974 DOI: 10.3390/s22031137
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
ALS participants clinical records. Notation: Age (in years). ALSFR-R (Rating Scale-Revised): scores (0–48) the severity of ALS; Bulbar: Bulbar involvement; NA: Data not available.
| Age | Sex | ALSFR-R | Bulbar | Bulbar Onset Symptoms |
|---|---|---|---|---|
| 37 | F | 37 | NO | No Symptoms |
| 38 | M | 6 | YES | NA |
| 39 | M | 43 | NO | No Symptoms |
| 41 | M | 34 | NO | No Symptoms |
| 41 | M | 34 | NO | No Symptoms |
| 43 | F | 21 | YES | Dysphagia |
| 44 | F | 19 | NO | No Symptoms |
| 48 | F | 36 | NO | No Symptoms |
| 48 | F | 29 | YES | Dysphagia |
| 48 | M | 31 | NO | No Symptoms |
| 48 | M | 45 | NO | No Symptoms |
| 49 | M | NA | NO | No Symptoms |
| 50 | M | 39 | NO | No Symptoms |
| 52 | M | 43 | NO | No Symptoms |
| 52 | F | 27 | YES | Dysphagia |
| 52 | M | 33 | NO | No Symptoms |
| 53 | F | 29 | YES | Dysphagia/Dysarthria |
| 55 | M | 26 | NO | No Symptoms |
| 55 | M | 24 | NO | No Symptoms |
| 56 | M | 35 | NO | No Symptoms |
| 56 | M | 27 | NO | No Symptoms |
| 58 | F | 46 | YES | Dysarthria |
| 58 | M | 28 | YES | NA |
| 59 | F | 33 | YES | NA |
| 60 | M | 46 | YES | NA |
| 63 | M | 22 | NO | No Symptoms |
| 63 | M | 42 | NO | No Symptoms |
| 63 | M | NA | NO | No Symptoms |
| 65 | M | 24 | NO | No Symptoms |
| 66 | F | 41 | NO | No Symptoms |
| 67 | M | NA | NO | No Symptoms |
| 67 | F | 33 | YES | Dyspnoea |
| 68 | M | NA | NO | No Symptoms |
| 68 | F | 21 | NO | No Symptoms |
| 69 | M | 37 | NO | No Symptoms |
| 70 | F | 28 | YES | Dysphagia |
| 70 | F | 17 | NO | No Symptoms |
| 70 | M | 46 | NO | No Symptoms |
| 70 | M | 27 | NO | No Symptoms |
| 70 | F | 23 | YES | Dysphagia/Dysarthria |
| 71 | M | 39 | NO | No Symptoms |
| 71 | F | 32 | YES | Dysphagia |
| 72 | M | 30 | NO | No Symptoms |
| 72 | F | 38 | NO | No Symptoms |
| 76 | F | 30 | NO | No Symptoms |
| 81 | M | 36 | NO | No Symptoms |
| 81 | M | 28 | NO | No Symptoms |
| 84 | F | 30 | YES | NA |
Figure 1of vowel “a” for 3 different patients with bulbar involvement. The marked difference in the graphic representation of the time-frequency between the subjects can be clearly appreciated. (a) Patient pD without bulbar involvement. (b) Patient pD with slight bulbar involvement. (c) Patient pD with severe bulbar involvement.
Significant Features for males.
| Comparison | Feature | |
|---|---|---|
| C vs. B |
| 0.039 |
|
| <0.001 | |
|
| 0.001 | |
|
| 0.023 | |
|
| 0.016 | |
|
| <0.001 | |
|
| 0.046 | |
|
| 0.046 | |
|
| <0.001 | |
|
| 0.008 | |
|
| 0.027 | |
|
| 0.002 | |
| C vs. NB |
| 0.008 |
|
| 0.001 | |
|
| 0.008 | |
|
| 0.035 | |
|
| <0.001 | |
|
| 0.001 | |
|
| 0.002 | |
|
| 0.023 | |
|
| 0.001 | |
|
| 0.037 | |
|
| 0.045 | |
|
| 0.015 | |
|
| 0.045 | |
| B vs. NB |
| 0.044 |
|
| 0.028 | |
|
| <0.001 | |
|
| 0.011 | |
|
| 0.024 | |
|
| 0.009 | |
|
| 0.009 | |
|
| 0.045 | |
|
| <0.001 | |
| C vs. A |
| 0.009 |
|
| 0.001 | |
|
| 0.009 | |
|
| 0.044 | |
|
| <0.001 | |
|
| 0.001 | |
|
| 0.002 | |
|
| 0.015 | |
|
| <0.001 | |
|
| 0.046 | |
|
| 0.048 | |
|
| 0.034 |
Significant Features for females.
| Comparison | Feature | |
|---|---|---|
| C vs. B |
| 0.001 |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| 0.004 | |
|
| 0.029 | |
|
| 0.020 | |
|
| 0.003 | |
|
| <0.001 | |
|
| 0.013 | |
|
| 0.028 | |
| C vs. NB |
| <0.001 |
|
| <0.001 | |
|
| <0.001 | |
|
| 0.003 | |
|
| 0.008 | |
|
| <0.001 | |
|
| 0.011 | |
|
| 0.015 | |
|
| 0.014 | |
|
| 0.022 | |
| B vs. NB |
| <0.001 |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| 0.029 | |
|
| <0.001 | |
|
| 0.026 | |
|
| 0.048 | |
| C vs. A |
| <0.001 |
|
| 0.001 | |
|
| 0.004 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| 0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| <0.001 | |
|
| 0.003 | |
|
| 0.006 | |
|
| 0.005 | |
|
| 0.003 | |
|
| 0.049 | |
|
| 0.001 | |
|
| 0.049 | |
|
| 0.039 | |
|
| 0.018 |
Performance of male models. RF: Random Forest; LR: Logistic Regression; LDA: Linear Discriminant Analysis; NN: Neuronal Networks; SVM: Support Vector Machines.
| C vs. B | C vs. NB | B vs. NB | C vs. A | ||
|---|---|---|---|---|---|
| RF | Accuracy |
| 91.9 |
| 92.0 |
| Sensitivity | 86.1 |
| 55.0 |
| |
| Specificity |
| 91.0 |
| 87.0 | |
| LR | Accuracy | 91.9 | 89.2 | 88.5 | 91.3 |
| Sensitivity |
| 90.3 | 75.0 | 90.7 | |
| Specificity | 92.0 | 86.9 | 89.5 | 94.0 | |
| LDA | Accuracy | 95.0 | 91.1 | 81.3 | 92.0 |
| Sensitivity | 85.0 | 88.6 |
| 90.7 | |
| Specificity |
| 98.0 | 80.5 | 96.0 | |
| NN | Accuracy | 95.0 | 90.0 | 86.1 | 92.0 |
| Sensitivity | 90.0 | 91.3 | 75.0 | 91.5 | |
| Specificity | 95.0 | 86.5 | 88.4 | 93.0 | |
| SVM | Accuracy | 93.3 |
| 86.1 |
|
| Sensitivity | 85.0 | 91.2 | 85.0 | 90.7 | |
| Specificity | 95.0 |
| 86.7 |
|
Performance of female models. RF: Random Forest; LR: Logistic Regression; LDA: Linear Discriminant Analysis; NN: Neuronal Networks; SVM: Support Vector Machines.
| C vs. B | C vs. NB | B vs. NB | C vs. A | ||
|---|---|---|---|---|---|
| RF | Accuracy |
|
|
|
|
| Sensitivity |
|
|
|
| |
| Specificity |
| 95.5 |
| 96.0 | |
| LR | Accuracy | 91.4 | 93.0 | 74.7 | 91.3 |
| Sensitivity | 91.3 | 90.0 | 75.0 | 93.4 | |
| Specificity | 91.5 | 95.5 |
| 87.0 | |
| LDA | Accuracy | 93.1 | 90.4 | 72.1 | 90.7 |
| Sensitivity | 87.6 | 82.5 | 70.0 | 87.3 | |
| Specificity | 86.6 |
|
|
| |
| NN | Accuracy | 93.2 | 86.9 | 71.1 | 90.6 |
| Sensitivity | 93.3 | 85.0 | 72.3 | 93.6 | |
| Specificity | 94.0 | 89.0 | 70.0 | 84.5 | |
| SVM | Accuracy | 95.1 | 91.6 | 74.2 | 93.6 |
| Sensitivity | 93.3 | 90.0 | 73.6 | 94.7 | |
| Specificity | 97.5 | 93.0 |
| 91.5 |